Drawing for FEMTOLAB

USPTO serial 76073756

FEMTOLAB

Reviewed by CopyMark Law Group

Reg. 2927100Status 710
Filing date
Status date
Registration date
Feb 22, 2005
Examiner
CHARLON, BARNEY
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with FEMTOLAB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical products for industrial use and scientific purposes, namely, buffers, chemically derived antibodies, enzyme substrates, and inorganic acids used for detection of health threatening substances in the environment; reagent test strips and test equipment sold as a kit that contain the solutions for performing analytical reactions for environmental analysis, toxicological analysis, foodstuff analysis, pharmacological analysis; chemical, biochemical and biological products for performing analytical studies for medical and veterinary research, namely, antibodies, antibody derivatives obtained through proteolysis, genetic engineering or chemical conjugation, namely conjugation with biotin, enzymes, fluorochromes chelating substances, unstable or rare isotopes, colored nano-particles, or immobilization on plastic surfaces or porous membranes for scientific and research purposes, in particular, diagnosis of disease, determination of health status of humans and animals, and detection of health threatening substances in the environment; chemical, biochemical and biological products for the performing of analytical studies, namely, monoclonal antibodies, antibody derivatives obtained through proteolysis, genetic engineering or chemical conjugation, namely conjugation with biotin, enzymes, luorochromes chelating substances, unstable or rare isotopes, colored nano-particles, or immobilization on plastic surfaces or porous membranes for scientific and/or research use, in particular, for the diagnosis of bodily excretions, namely, stool samples, urine, saliva, condensate from exhaled breath, whole blood, serum and cerebrospinal fluid, for the detection of microorganisms, bacteria, fungi, viruses, parasites, and their products, toxins, lectins, adhesions, and/or enzymes, as disease causing agents or indicators of the presence of these organisms or pathogenicity in the body and on internal body surfaces, detection and quantification of secretory products of exocrine glands as indicators of pathological conditions, detection of substances indicating malignant transformation of cells, DNA, RNA, proteins, peptides, or polysaccharides, derived from malignant cells or surrounding tissues triggered by the existence of malignant cells to produce such substances; chemical products for industrial use and scientific purposes, namely, buffers, chemically derived antibodies, enzyme substrates, and inorganic acids used for diagnosis of disease, health determinations of humans and other animalsSECTION 8 - CANCELLED
005Reagent test strips and test equipment sold as a kit for clinical medical and veterinary medicine purpose; diagnostic preparations, reagent and reagent mixtures for the medical and veterinary medicine field; chemical, biochemical and biological products for clinical medical and veterinary medicine, namely, antibodies, antibody derivatives obtained through proteolysis, genetic engineering or chemical conjugation, namely conjugation with biotin, enzymes, fluorochromes chelating substances, unstable or rare isotopes, colored nano-particles, or immobilization on plastic surfaces or porous membranesSECTION 8 - CANCELLED
009Apparatus and instruments for industrial and scientific studies in laboratories, in particular, electrical apparatus, namely, for analysis of multiple samples and/or analysis for multiple parameters in a fully or partially automated manner, apparatus and instruments for preanalytical preparation of samples for such analytical procedures, and optical analysis devices, namely photometric analysis devices for photometry of test strips or multiple samples in rapid sequence or parallel, all for use in development of diagnostic procedures and biopharmeceuticals based on monoclonal antibodies and derivatives; devices and test components sold as a kit for the collection, preservation and shipment of bodily excretions in a simple, reproducible and hygienic manner, for preanalytical sample preparation by dilution, mixing, filtration, centrifugation, specific adsorption and desorption to prepare samples for analytical studies of human and animal samples, in particular, blood, urine, stool and other bodily fluids for scientific research use, for the analysis of agricultural products, for environmental analysis, and for toxicological analysis purposes; test kits for scientific research consisting of reaction vessels, in particular, coated reaction vessels in the nature of microtitration plates or reaction tubes, reagents, reagent mixtures, substrates, buffer substances, in particular, solutions for the performing of analyses in the nature of buffer solutions, control solutions, substrate solutions, stopping reagents; reaction vessels for laboratory diagnostics and analysis; devices for collecting of samples for scientific purposesSECTION 8 - CANCELLED
010Devices for the collection of samples for medical purposes; devices and test components sold as a kit for the collection, preservation and shipment of bodily excretions in a simple, reproducible and hygienic manner, for preanalytical sample preparation by dilution, mixing, filtration, centrifugation, specific adsorption and desorption to prepare samples for analytical studies of human and animal samples, in particular, blood, urine, stool and other bodily fluids for clinical medical and veterinary purposesSECTION 8 - CANCELLED
042Performing of diagnostic and analytical procedures, in particular, for environmental analysis, toxicological analysis, foodstuff analysis, pharmacological analysisSECTION 8 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 21, 2012C8..CANCELLED SEC. 8 (6-YR)
Feb 22, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 30, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 10, 2004NPUBNOTICE OF PUBLICATION
Oct 1, 2004CFITCASE FILE IN TICRS
Sep 24, 2004PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 23, 2004ALIEASSIGNED TO LIE
Aug 3, 2004ALIEASSIGNED TO LIE
Aug 3, 2004ALIEASSIGNED TO LIE
Jul 30, 2004ALIEASSIGNED TO LIE
May 18, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2004CNEAEXAMINERS AMENDMENT MAILED
Feb 19, 2004ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 19, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 25, 20031.BDSec. 1(B) CLAIM DELETED
Oct 28, 2003CNEAEXAMINERS AMENDMENT MAILED
May 19, 2003CNCFCONTINUATION OF FINAL REFUSAL MAILED
Mar 31, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2003MAILPAPER RECEIVED
Sep 30, 2002CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 19, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 19, 2002MAILPAPER RECEIVED
Mar 4, 2002CNSLLETTER OF SUSPENSION MAILED
Jul 25, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 28, 2000DOCKASSIGNED TO EXAMINER
Dec 18, 2000DOCKASSIGNED TO EXAMINER
Sep 18, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE

Frequently asked questions

Related guidance